Industry alerts policymakers to devices as population ages:
This article was originally published in Clinica
Executive Summary
The European medical device industry association, Eucomed, has issued a press release drawing attention to the growing importance of medical devices in the years ahead as the population ages. According to that release, issued on the International Day of Older Persons on October 1, some 10% of the population is now 60 years of over - by 2050, this figure will reach 20% and by 2150, 33%. There are striking differences between regions, it says, with 20% of Europeans but just 5% of Africans 60 or over. During the first half of the 21st century, the proportion of over 60s in Europe will reach one in four in some countries, and even one in two in others. The potential for medical devices to help eliminate or greatly reduce the disabilities related to ageing and lead to more active lives is clear. Eucomed calls for equitable access to the simple devices - such as hearing aids and incontinence pads - as well as to the more high-tech devices that can dramatically improve the quality of life of older people with a life-threatening condition - such as heart valves or implantable pacemakers.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.